And when a ribosome reads from this mRNA to make the protein, it reads inosine as though it was guanine. Thus, A-to-I mRNA ...

A new trial suggests a combination vaccine may offer equal or better protection against both flu and covid-19 compared to ...

Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...

In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1389.55 with a total volume of ...

Galit Meshulam-Simon is the associate director of Commercial Applications at Elegen. COVID-19 brought messenger RNA (mRNA) into the global spotlight, demonstrating its speed, flexibility, and efficacy ...

This is false and revives a debunked conspiracy theory on efforts to vaccinate people unknowingly through food; mRNA vaccines are not currently approved for use in livestock in the United States ...

Of course, a lot of upside could potentially be left on the table if MRNA shares really soar, which is why looking at the trailing twelve month trading history for Moderna Inc, as well as studying ...

With a market cap of $9.3 billion, Moderna, Inc. (MRNA) is a biotechnology company specializing in the development of messenger RNA (mRNA) therapeutics and vaccines. Known for its COVID-19 vaccine ...

Lawmakers in Iowa, Montana, Idaho, Texas and Kentucky introduced bills that would ban or restrict vaccines that use messenger RNA, or mRNA, technology — despite its immense potential for ...

Seven percent of 108 healthy volunteers reported urticaria; unresolved urticaria persisted at 12 months in four participants.